Wisconsin is currently home to 1341 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Milwaukee, Madison, Green Bay and Marshfield. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Structural Stability of Carotid Plaque and Symptomatology
NCT02476396
Recruiting
The purpose of the research is to understand structural plaque abnormalities that make a carotid plaque unstable and brake off (embolize) which would help to predict and treat individuals who are likely to suffer not only classic episodic major strokes but also cognitive impairment.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/18/2023
Locations: University of Wisconsin-Madison, Madison, Wisconsin
Conditions: Carotid Stenosis, Stroke, Carotid Artery Plaque, Transient Ischemic Attack, Cerebrovascular Accident, Carotid Artery Stenosis
Register for Updates
Diabetes Education/Skills Training and Social Needs Resolution Intervention
NCT05935410
Recruiting
This study will test the preliminary efficacy of a nurse case-manager, telephone-delivered intervention that provides diabetes self-management education and skills training and resolves the unmet social needs of older African Americans with poorly controlled type 2 diabetes by randomizing 100 African Americans aged 50 years and older with poorly controlled type 2 diabetes to the Combined Diabetes Education/Skills Training and Social Needs Resolution (DM Social Needs) Intervention (n=50) and usua... Read More
Gender:
All
Ages:
50 years and above
Trial Updated:
10/17/2023
Locations: Aprill Dawson, Milwaukee, Wisconsin
Conditions: Type 2 Diabetes
Register for Updates
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
NCT03971591
Recruiting
This study will examine the efficacy of Men Moving Forward (MMF), a four-month community-based lifestyle intervention designed for AA PC survivors. MMF is rooted in the evidence-based Moving Forward lifestyle intervention developed with and for AA breast cancer survivors. This intervention was adapted in collaboration with AA PC survivors. It will offer twice weekly sessions aimed at supporting adherence to the ACS nutrition and physical activity guidelines to promote improved body composition (... Read More
Gender:
Male
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: Medical College of Wisconsin, Milwaukee, Wisconsin
Conditions: Prostate Cancer
Register for Updates
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT03860883
Recruiting
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
Conditions: Cutaneous Melanoma, Stage II
Register for Updates
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
NCT05981963
Recruiting
The purpose of this study is to evaluate the excretion pathway of orally administered [14C]-BMS-986196 and to assess the safety and tolerability of orally administered BMS-986196.
Gender:
Male
Ages:
Between 18 years and 55 years
Trial Updated:
10/16/2023
Locations: Covance Clinical Research Unit - Madison, Madison, Wisconsin
Conditions: Healthy Male Volunteers
Register for Updates
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
NCT02688959
Recruiting
The investigators will perform a feasibility/pilot trial of two non-pharmacological interventions for ADHD in college students.
Gender:
All
Ages:
Between 18 years and 23 years
Trial Updated:
10/16/2023
Locations: University of Wisconsin-Madison, Waisman Center, Madison, Wisconsin
Conditions: Attention Deficit Hyperactivity Disorder
Register for Updates
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
NCT04683315
Recruiting
This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/15/2023
Locations: Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin
Conditions: Pancreatic Cancer
Register for Updates
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy
NCT05961332
Recruiting
The goal of this clinical trial is to compare measurements of geographic atrophy (GA) area between several types of imaging, in order to assess accuracy. The main question to answer is which imaging device provides measurements that are most similar to the standard of care device. Participants will be patients of a retina doctor at University Station Eye Clinic with geographic atrophy, and can expect to be in the study for 60-75 minutes.
Gender:
All
Ages:
50 years and above
Trial Updated:
10/13/2023
Locations: University of Wisconsin, Madison, Wisconsin
Conditions: Macular Degeneration, Age Related, Geographic Atrophy
Register for Updates
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
NCT05243680
Recruiting
The purpose of this open-label 12-month extension study is to continue to characterize the long-term safety, efficacy and immunogenic profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studies 206713 or 213744.
Gender:
All
Ages:
12 years and above
Trial Updated:
10/13/2023
Locations: GSK Investigational Site, Milwaukee, Wisconsin
Conditions: Asthma
Register for Updates
Intra- and Inter-fraction Changes in Radiation Therapy
NCT02344121
Recruiting
Analysis to quantify intra-fraction, inter-fraction and post-treatment changes in tumor target volumes and surrounding normal organs in radiation therapy.
Gender:
All
Ages:
All
Trial Updated:
10/12/2023
Locations: Froedtert Hospital, Milwaukee, Wisconsin
Conditions: Cancer
Register for Updates
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT05721755
Recruiting
This phase III trial compares pembrolizumab with radiation therapy to pembrolizumab without radiation therapy (standard therapy) given after pembrolizumab plus chemotherapy for the treatment of patients with squamous cell carcinoma of the head and neck that has spread from where it first started (primary site) to other places in the body (metastatic). Pembrolizumab is a type of immunotherapy that stimulates the body's immune system to fight cancer cells. Pembrolizumab targets and blocks a protei... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/10/2023
Locations: ProHealth D N Greenwald Center, Mukwonago, Wisconsin
Conditions: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Register for Updates
Muscle Function After Childbirth
NCT05073224
Recruiting
This study will evaluate lower extremity and trunk neuromuscular control in 78 nulligravid and postpartum women. Participants will attend two experimental sessions, approximately 1 week apart, to assess neuromuscular function. Physical activity levels will also be assessed.
Gender:
Female
Ages:
Between 20 years and 35 years
Trial Updated:
10/06/2023
Locations: University of Wisconsin, Madison, Wisconsin
Conditions: Postpartum, Muscle Fatigue, Force Steadiness, Nulligravid, Muscle Weakness
Register for Updates